In an adult liver transplant recipient with rim‑enhancing hypodense lesions in the graft on imaging, what is the recommended evaluation and initial management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Rim-Enhanced Hypodense Lesions in Transplanted Liver

In a liver transplant recipient with rim-enhancing hypodense lesions, immediately obtain multiphase contrast-enhanced CT or MRI with hepatobiliary contrast to differentiate between infectious/inflammatory complications (abscess, biliary cast syndrome), vascular complications (infarction, arterial thrombosis), and malignancy (HCC recurrence, PTLD, metastases).

Initial Diagnostic Approach

The differential diagnosis for rim-enhancing hypodense lesions in a transplanted liver is broad and includes life-threatening complications that require urgent intervention 1, 2.

Priority Imaging Evaluation

  • Multiphase contrast-enhanced CT is the workhorse modality for acute evaluation, particularly when vascular complications or abscess are suspected 1, 3
  • MRI with hepatobiliary contrast provides superior tissue characterization and is particularly useful for distinguishing biliary complications from other etiologies 1, 2
  • Doppler ultrasound should be performed urgently if hepatic artery thrombosis is suspected, as this is the most devastating vascular complication 1, 3

Critical Clinical Context to Obtain

Timing post-transplant:

  • Early (<3 months): Consider hepatic artery thrombosis with resultant infarction/abscess, acute rejection with necrosis, or infection (bacterial abscess, fungal infection) 1, 2
  • Late (>1 year): Consider HCC recurrence, PTLD, biliary complications, or de novo malignancy 4, 5

Immunosuppression status:

  • Patients on high-dose immunosuppression are at increased risk for PTLD (2% in adults, 15% in pediatrics), typically EBV-related and occurring within the first year 5
  • Cannabis use may increase fungal infection risk from contaminated spores 5

Original transplant indication:

  • HCC patients have 8-20% recurrence risk, typically within first 2 years post-transplant 4
  • Recurrent HCC typically presents with systemic dissemination 4

Specific Diagnostic Considerations

Infectious/Inflammatory Etiologies

Hepatic abscess presents with rim enhancement on arterial phase with central hypodensity. Look for:

  • Fever, elevated inflammatory markers
  • Recent biliary intervention or hepatic artery thrombosis (predisposes to ischemic biliary necrosis and secondary infection) 1, 2

Biliary cast syndrome results from ischemic biliary mucosa sloughing into ducts, causing obstruction. This is a unique post-transplant complication related to arterial ischemia since the biliary tree depends solely on hepatic arterial supply 5, 1

Vascular Complications

Hepatic artery thrombosis:

  • Early thrombosis is catastrophic; delayed thrombosis may be insidious as collaterals develop 1
  • Results in geographic areas of infarction that can appear as rim-enhancing hypodense lesions 2
  • Doppler US findings may be similar between hepatic artery stenosis, thrombosis, and celiac artery stenosis 1

Malignant Etiologies

HCC recurrence should be monitored with 6-12 monthly contrast-enhanced CT or MRI plus α-fetoprotein measurements 4. Recurrence typically occurs within 2 years and carries median survival <1 year from diagnosis 4.

PTLD occurs in ~2% of adult recipients, usually within first year, and is 80-90% associated with EBV infection 5. Treatment involves reducing immunosuppression, but this must be balanced against rejection risk.

De novo malignancies are increased due to prolonged immunosuppression, with cutaneous malignancies being most common (up to 100-fold increased incidence) 5.

Management Algorithm

  1. Obtain complete imaging characterization with multiphase CT or MRI immediately 1, 2

  2. Assess hepatic arterial patency with Doppler US if not already performed 1, 3

  3. Check laboratory markers:

    • Liver function tests, inflammatory markers
    • α-fetoprotein (if original indication was HCC) 4
    • EBV PCR if PTLD suspected 5

  4. Consider image-guided biopsy for definitive diagnosis when imaging is indeterminate, particularly to distinguish between infection, rejection, and malignancy 2

  5. Coordinate with transplant center for all management decisions, as immunosuppression adjustment may be required 5, 6

Common Pitfalls

  • Delayed hepatic artery thrombosis can be missed on Doppler US due to collateral formation; maintain high suspicion and proceed to CT angiography if clinical suspicion persists 1
  • Biliary complications often result from arterial ischemia even when arterial flow appears patent 1
  • Reducing immunosuppression for suspected PTLD or malignancy must be done by the transplant center to avoid precipitating rejection 5, 6
  • Rim enhancement can be seen in both benign (abscess, organizing hematoma) and malignant lesions; multiparametric MRI is superior to CT for differentiation 7

References

1
Research

Multimodality Imaging after Liver Transplant: Top 10 Important Complications.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2022

3
Research

Postoperative imaging in liver transplantation: what radiologists should know.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2010

Related Questions

What is the recommended management for a patient with greater than 50% stenosis of the tibioperoneal trunk artery?
In a 50-year-old man with intermittent left-sided penile pain during erection and a mild penile curvature, what are the next steps in evaluation and management?
How should I manage a 18-year-old patient presenting with post‑coital bleeding?
In a patient with three days of progressively worsening right anterior leg pain and shin swelling, severe constant pain at rest, and no trauma, erythema, fever, or systemic signs, what is the most likely diagnosis?
How should a 74-year-old patient with nocturnal leg cramps be evaluated and managed?
Is a slightly larger left lateral ventricle compared to the right a normal finding?
What are the possible causes of a palpable lump or knot in the lumbar region (e.g., lymphadenopathy, lipoma, cyst, tumor) and how should it be evaluated and managed?
What is the difference between a central line‑associated bloodstream infection (CLABSI) and a catheter‑related bloodstream infection (CRBSI)?
What are the recommended dosing, monitoring, and contraindications for using eplerenone to treat ascites in adults with chronic liver disease (cirrhosis)?
Are intradermal hyaluronic‑acid skin‑booster injections effective for improving skin hydration, smoothness, and fine‑line appearance?
What is the recommended pneumococcal conjugate vaccine (PCV) schedule for a child, including routine doses, catch‑up dosing, and booster timing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.